As rural India develops taste for chocolate, a dominant Mondelez extends its reach
Two years ago, Satish P., a bakery owner in the small village of Harohalli near Bengaluru, had his doubts about stocking Mondelez’s Cadbury Silk bars.
U.S., China move trade talks to Shanghai amid deal pessimism
U.S. and Chinese trade negotiators shift to Shanghai this week for their first in-person talks since a G20 truce last month, a change of scenery for two sides struggling to resolve deep differences on how to end a year-long trade war.
Exclusive: BlackRock in talks to take over Cofense after U.S. security concerns – sources
BlackRock Inc , an investor in Cofense Inc, is in advanced talks to take over the U.S. cyber security firm, after a U.S. national security panel asked buyout firm Pamplona Capital Management LLP to sell its stake, people familiar with the matter said o…
LSE-Refinitiv deal faces long antitrust review: sources
U.S. buyout fund Blackstone Group Inc is expected to announce the merger of its majority-owned financial data firm Refinitiv with the London Stock Exchange Group Plc within a week, but the deal is expected to face a long antitrust review before it ca…
SABIC CEO says no interest in taking over Clariant
Saudi Basic Industries Corp (SABIC) has no interest in taking over Swiss chemicals firm Clariant and considers its 25% stake in the company as “a long term strategic investment,” said its chief executive Yousef al-Benyan on Sunday.
LSE’s bid for Refinitiv spotlights quest for data, globality
London Stock Exchange Group Plc’s planned purchase of Refinitiv in a $27 billion deal is the latest sign that exchange operators are focusing more on data products to increase revenue, while also trying to expand their global reach.
Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg
Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday.
Pfizer in talks to merge off-patent drugs business with Mylan: source
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter.
Bosch sees car production falling 5% in 2019: report
Auto supplier Robert Bosch has revised its forecast for automotive production on Saturday, expecting a 5% fall this year, bigger than an earlier estimate for a 3% decline, the company’s chief financial officer told Boersen-Zeitung.
Pfizer in talks to merge off-patent drugs business with Mylan
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
